CAPTRUST Financial Advisors
HRMY icon

CAPTRUST Financial Advisors’s Harmony Biosciences HRMY Stock Holding History

CAPTRUST Financial Advisors’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$312K Buy
+8,562
New +$270K ﹤0.01% 2558
2026
Q1 		– Sell
-6,216
Closed -$233K – 3082
2025
Q4 		$233K Buy
+6,216
New +$204K ﹤0.01% 2427
2022
Q3 		– Sell
-432
Closed -$21K – 2953
2022
Q2 		$21K Buy
432
+278
+181% +$12.5K ﹤0.01% 3344
2022
Q1 		$7K Sell
154
-26
-14% -$1.06K ﹤0.01% 3965
2021
Q4 		$8K Buy
180
+171
+1,900% +$6.82K ﹤0.01% 3849
2021
Q3 		$0 Hold
9
– – ﹤0.01% 4690
2021
Q2 		$0 Buy
+9
New +$270 ﹤0.01% 4576

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CAPTRUST Financial Advisors's HRMY Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Harmony Biosciences (HRMY) in Q2 2026: 8,562 shares worth $312K. The stake represents ﹤0.01% of the portfolio and ranks #2558 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in HRMY as recently as Q4 2025.

CAPTRUST Financial Advisors first reported a position in HRMY in Q2 2021 and has held it in 7 quarters since. 328 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • CAPTRUST Financial Advisors held 8,562 shares of Harmony Biosciences worth $312K as of Q2 2026.
  • Harmony Biosciences was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Harmony Biosciences made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #2558 holding.
  • CAPTRUST Financial Advisors first reported a position in Harmony Biosciences in Q2 2021 and has held it in 7 quarters since.
  • 328 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.